292 related articles for article (PubMed ID: 24263531)
1. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.
Cara-Fuentes G; Wei C; Segarra A; Ishimoto T; Rivard C; Johnson RJ; Reiser J; Garin EH
Pediatr Nephrol; 2014 Aug; 29(8):1363-71. PubMed ID: 24263531
[TBL] [Abstract][Full Text] [Related]
2. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.
Garin EH; Mu W; Arthur JM; Rivard CJ; Araya CE; Shimada M; Johnson RJ
Kidney Int; 2010 Aug; 78(3):296-302. PubMed ID: 20485332
[TBL] [Abstract][Full Text] [Related]
3. The utility of urinary CD80 as a diagnostic marker in patients with renal diseases.
Minamikawa S; Nozu K; Maeta S; Yamamura T; Nakanishi K; Fujimura J; Horinouchi T; Nagano C; Sakakibara N; Nagase H; Shima H; Noda K; Ninchoji T; Kaito H; Iijima K
Sci Rep; 2018 Nov; 8(1):17322. PubMed ID: 30470792
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome.
Mishra OP; Kumar R; Narayan G; Srivastava P; Abhinay A; Prasad R; Singh A; Batra VV
Pediatr Nephrol; 2017 Aug; 32(8):1355-1361. PubMed ID: 28210837
[TBL] [Abstract][Full Text] [Related]
5. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance: response.
Cara-Fuentes G; Johnson RJ; Reiser J; Garin EH
Pediatr Nephrol; 2014 Aug; 29(8):1467-8. PubMed ID: 24817342
[No Abstract] [Full Text] [Related]
6. CD80 and suPAR: diagnostic and pathogenic value in minimal change disease and focal segmental glomerulosclerosis?
Davin JC
Pediatr Nephrol; 2014 Aug; 29(8):1465-6. PubMed ID: 24839215
[No Abstract] [Full Text] [Related]
7. Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease.
Ahmed HM; Ezzat DA; Doudar NA; Adel M
Iran J Kidney Dis; 2018 Mar; 12(2):107-111. PubMed ID: 29507273
[TBL] [Abstract][Full Text] [Related]
8. Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis.
Garin EH; Reiser J; Cara-Fuentes G; Wei C; Matar D; Wang H; Alachkar N; Johnson RJ
Pediatr Nephrol; 2015 Mar; 30(3):469-77. PubMed ID: 25239302
[TBL] [Abstract][Full Text] [Related]
9. CD80, suPAR and nephrotic syndrome in a case of NPHS2 mutation.
Cara-Fuentes G; Araya C; Wei C; Rivard C; Ishimoto T; Reiser J; Johnson RJ; Garin EH
Nefrologia; 2013; 33(5):727-31. PubMed ID: 24089165
[TBL] [Abstract][Full Text] [Related]
10. Urinary CD80 excretion is a predictor of good outcome in children with primary nephrotic syndrome.
Ling C; Liu X; Shen Y; Chen Z; Fan J; Jiang Y; Meng Q
Pediatr Nephrol; 2018 Jul; 33(7):1183-1187. PubMed ID: 29569191
[TBL] [Abstract][Full Text] [Related]
11. Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS.
Li F; Zheng C; Zhong Y; Zeng C; Xu F; Yin R; Jiang Q; Zhou M; Liu Z
Clin J Am Soc Nephrol; 2014 Nov; 9(11):1903-11. PubMed ID: 25318750
[TBL] [Abstract][Full Text] [Related]
12. Patients with primary focal segmental glomerulosclerosis with detectable urinary CD80 are more similar to patients with minimal change disease in clinicopathological features.
Gong X; Huang J; Zhang Y; Wang F; Wang X; Meng L; Cheng X; Liu G; Cui Z; Zhao M
Ren Fail; 2023; 45(2):2279642. PubMed ID: 37942512
[TBL] [Abstract][Full Text] [Related]
13. Urinary CD80 and Serum suPAR as Biomarkers of Glomerular Disease among Adults in Brazil.
Zen RC; Dominguez WV; Braga I; Dos Reis LM; Jorge LB; Yu L; Woronik V; Dias CB
Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673014
[TBL] [Abstract][Full Text] [Related]
14. Urinary fibrinogen and renal tubulointerstitial fibrinogen deposition: Discriminating between primary FSGS and minimal change disease.
Wang Y; Zheng C; Xu F; Liu Z
Biochem Biophys Res Commun; 2016 Sep; 478(3):1147-52. PubMed ID: 27539323
[TBL] [Abstract][Full Text] [Related]
15. Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis.
Pérez V; López D; Boixadera E; Ibernón M; Espinal A; Bonet J; Romero R
BMC Nephrol; 2017 Feb; 18(1):49. PubMed ID: 28158993
[TBL] [Abstract][Full Text] [Related]
16. Urinary low-molecular-weight protein excretion in pediatric idiopathic nephrotic syndrome.
Chehade H; Parvex P; Poncet A; Werner D; Mosig D; Cachat F; Girardin E
Pediatr Nephrol; 2013 Dec; 28(12):2299-306. PubMed ID: 23949592
[TBL] [Abstract][Full Text] [Related]
17. Urinary CD80 levels as a diagnostic biomarker of minimal change disease.
Ling C; Liu X; Shen Y; Chen Z; Fan J; Jiang Y; Meng Q
Pediatr Nephrol; 2015 Feb; 30(2):309-16. PubMed ID: 25142334
[TBL] [Abstract][Full Text] [Related]
18. Rationale and design of the Japanese Biomarkers in Nephrotic Syndrome (J-MARINE) study.
Kurasawa S; Kato S; Ozeki T; Akiyama S; Ishimoto T; Mizuno M; Tsuboi N; Kato N; Kosugi T; Maruyama S;
Clin Exp Nephrol; 2024 May; 28(5):431-439. PubMed ID: 38267800
[TBL] [Abstract][Full Text] [Related]
19. Glomerular endothelial cells and podocytes can express CD80 in patients with minimal change disease during relapse.
Cara-Fuentes G; Venkatareddy M; Verma R; Segarra A; Cleuren AC; Martínez-Ramos A; Johnson RJ; Garg P
Pediatr Nephrol; 2020 Oct; 35(10):1887-1896. PubMed ID: 32399663
[TBL] [Abstract][Full Text] [Related]
20. Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis.
Huang J; Liu G; Zhang YM; Cui Z; Wang F; Liu XJ; Chu R; Zhao MH
BMC Med; 2014 May; 12():81. PubMed ID: 24884842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
